Form D/A — Basking Biosciences, Inc.
0001824142-25-000003 · filed Oct 22, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $55,000,000
- Reported amount sold
- $55,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Basking Biosciences, Inc.
- CIK
- 1824142
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 964 High House Rd #3268
Cary, North Carolina 27513 - Phone
- 919-345-7933
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Julia Owens · Executive OfficerCary, North Carolina Find on LinkedIn ↗
-
Steve Gillis · DirectorCary, North Carolina Find on LinkedIn ↗
-
Ari Nowacek · DirectorCary, North Carolina Find on LinkedIn ↗
-
Thomas Needham · DirectorCary, North Carolina Find on LinkedIn ↗
-
Aiden Aceves · DirectorCary, North Carolina Find on LinkedIn ↗
-
Hannah Chang · DirectorCary, North Carolina Find on LinkedIn ↗
-
David Adair · DirectorCary, North Carolina Find on LinkedIn ↗
-
Shahid Nimjee · DirectorCary, North Carolina Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗